×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
[Session 6] Drug Induced Cardiovascular and Hemodynamic Changes
Session Chair(s)
Koki Nakamura, MD, PhD
Vice President, CVM Marketing, Japan Pharma Business Unit
Takeda Pharmaceutical Company Limited, Japan
Kaori Shinagawa, MD, PhD
Senior Scientist for Clinical Medicine, Office of New Drug II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Cardiac Safety of Drug Treatment in Patient with Common Co Morbidities (Hypertension Hyperlipidemia DM)
Shinichiro Ueda, MD, PhD
University of the Ryukyus, Japan
Professor of Clinical Pharmacology & Therapeutics
Advanced Hemodynamic Monitoring in Clinical Trials
Jeff Heilbraun, MS
Clario, United States
Vice President, Medical and Scientific Affairs, Cardiology
Regulatory Update on Drug-Induced Blood Pressure Effects
Colette Strnadova, PhD
Health Canada, Canada
Senior Scientific Advisor, Therapeutic Products Directorate
Have an account?